Back
Charles River Laboratories International 10K Form
Buy
58
CRL
Charles River Laboratories International
Last Price:
229.02
Seasonality Move:
5.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2023-08-09 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2023-05-11 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2022-11-02 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2022-08-03 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2022-05-04 | 10Q | CRL/Charles River Laboratories International Quarterly |
Receive CRL News And Ratings
See the #1 stock for the next 7 days that we like better than CRL
CRL Financial Statistics
Sales & Book Value
| Annual Sales: | $4.13B |
|---|---|
| Cash Flow: | $142.62M |
| Price / Cash Flow: | 32.26 |
| Annual Sales: | $70.06 |
| Price / Book: | 3.27 |
Profitability
| EPS (TTM): | 9.23000 |
|---|---|
| Net Income (TTM): | $474.62M |
| Gross Margin: | $1.5B |
| Return on Equity: | 14.39% |
| Return on Assets: | 6.1% |
Charles River Laboratories International Earnings Forecast
Key Charles River Laboratories International Financial Ratios
- The Gross Profit Margin over the past 26 years for CRL is 36.39%.
- The Selling, General & Administrative Expenses for CRL have been equal to 18.11% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 28.80% of Operating Income.
- The Net Earning history of CRL is 11.49% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 17 years.
Charles River Laboratories International Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CRL |
| CUSIP: | 159864 |
| Website: | criver.com |
Debt
| Debt-to-Equity Ratio: | 0.74 |
|---|---|
| Current Ratio: | 1.52 |
| Quick Ratio: | 1 |
Price-to-Earnings
| Trailing P/E Ratio: | 24.84 |
|---|---|
| Forward P/E Ratio: | 18.42 |
CRL Technical Analysis vs Fundamental Analysis
Buy
58
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy or a Sell?
-
Charles River Laboratories International stock is rated a Buy
The current Charles River Laboratories International [CRL] share price is $229.03. The Score for CRL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.